Biolevate, founded in 2024, is at the forefront of transforming life sciences with its innovative AI-native Knowledge Platform. By connecting data, documents, and expertise, the company aims to help organizations turn knowledge into scalable intelligence, thereby standardizing and simplifying complex scientific workflows.
With the slogan "Elevate human, Automate the mundane," Biolevate empowers scientists, engineers, and experts by freeing them from tedious manual tasks, allowing them to prioritize discovery and innovation. This approach not only increases productivity but also accelerates the pace of scientific advancement.
The company's recent €6.00M seed investment on 01 November 2024 showcases strong investor interest, with backing from industry players like Bpifrance, EQT Ventures, and Mehdi Ghissassi. This capital infusion is set to propel Biolevate in scaling its offering and expanding its market reach, making it a promising prospect in the life sciences sector for potential investors.
